Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • LeonDK
    Member
    • Sep 2014
    • 69

    #1

    TMM normalization examplified and explained

    So according to the Robinson's 2010 paper on TMM normalization, the calculation of TMM factors, is given by:

    If we then take this hypothetical count matrix:
    Code:
        1   2   3   4   5
    a 711 662 138 424 604
    b 247 879 547 406 230
    c 390 891 678 919 967
    d  92 567 529 809 605
    e 963 594  87 541 640
    f  11 365 620 108 919
    g 575 358  32 455 148
    h 765 592 462  52 330
    i 874 866 331 759 733
    j  42 681 634  84 681
    Could anyone briefly exemplify how to perform the calculation of the TMM factors manually?

    I realise, that I can the normalization factors like so:
    Code:
    R
    library(edgeR)
    set.seed(13)
    counts = as.data.frame(matrix( floor(runif(10*5,1,1001)), 10, 5))
    rownames(counts) = letters[1:10]
    colnames(counts) = seq(1,5)
    d = DGEList(counts=counts)
    d = calcNormFactors(d,method="TMM”)
    d$samples$norm.factors
    [1] 0.9412422 0.9510114 0.9604313 1.1794450 0.9862088
    But i'd love to do a manual calculation, to understand the details of exactly how the TMM values are calculated

    Cheers,
    Leon
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Just look at the code for calcNormFactors. I recall it being fairly short.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 07:41 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...